Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer.
Segami K, Aoyama T, Hiroshima Y, Komori K, Hashimoto I, Watanabe H, Kano K, Nagasawa S, Nakazono M, Maezawa Y, Fujikawa H, Numata M, Yamada T, Tamagawa H, Yamamoto N, Ogata T, Siozawa M, Yukawa N, Morinaga S, Rino Y, Masuda M, Miyagi Y, Saeki H, Oshima T.
Segami K, et al. Among authors: nakazono m.
In Vivo. 2021 Sep-Oct;35(5):2771-2777. doi: 10.21873/invivo.12562.
In Vivo. 2021.
PMID: 34410967
Free PMC article.